Login to Your Account



Clinic Roundup


Friday, December 14, 2012
• Auxilium Pharmaceuticals Inc., of Malvern, Pa., disclosed top-line 30-day data for collagenase clostridium histolyticum for the potential treatment of adult patients with edematous fibrosclerotic panniculopathy, commonly known as cellulite.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription